降钙素基因相关肽对不同程度冠脉狭窄时的心脏功能的影响

本实验观察了冠脉内注射降钙素基因相关肽（ＣＧＲＰ０．３μｇ／ｋｇ）对正常及不同程度冠脉狭窄犬的心功能的影响。结果表明正常犬冠脉内注射ＣＧＲＰ后,平均动脉压（ＭＡＰ）下降１．２ｋＰａ（Ｐ＜０．０５）,同时,心率（ＨＲ）、心输出量（ＣＯ）、左室收缩压峰值（ＬＶＳＰ）均不同程度增加;左室舒张末压（ＬＶＥＤＰ）轻度降低。在中度狭窄３０ｍｉｎ后,冠脉内注射ＣＧＲＰ对ＨＲ、ＭＡＰ无明显影响;而重度狭窄后注射ＣＧＲＰ,ＭＡＰ由狭窄时降低逐渐增高,ＨＲ由增快而变慢。ＣＯ、ＬＶＳＰ均显著增高,ＬＶＥＤＰ降低,此作用较冠脉狭窄前更为明显。提示ＣＧＲＰ扩张冠脉动脉,增加冠脉血流量和心排血量,增强心肌收缩力,对缺血心脏功能有保护作用。     

胍基丁胺对大鼠血流动力学的影响及其细胞机制

在麻醉大鼠研究静注胍基丁胺（ＡＧＭ）对血流动力学的影响,并初步探讨其机制。结果如下：（１）静注ＡＧＭ（１０ｍｇ／ｋｇ）后,ＨＲ,ＭＡＰ,ＬＶＰ,±ＬＶｄｐ／ｄｔｍａｘ,ＣＩ和ＴＰＲＩ均明显下降;（２）预先静注ＮＯＳ抑制剂ＬＮＮＡ（１５ｍｇ／ｋｇ）或腹腔内注射鸟苷酸环化酶抑制剂亚甲基蓝（５０ｍｇ／ｋｇ）,均不能阻断ＡＧＭ的降压作用;（３）预先静注咪唑啉受体和α２肾上腺素能受体阻断剂ｉｄａｚｏｘａｎ（２ｍｇ／ｋｇ）则可明显阻抑ＡＧＭ的降压效应。以上结果表明,ＡＧＭ对麻醉大鼠的降压机制,在于显著抑制心肌收缩性而使心输出量降低,以及舒张外周血管致使总外周阻力下降;此效应似主要由ＩＲ和／或α２ＡＲ所介导。     

腺苷A_1受体激动剂对兔血一氧化氮水平及急性心肌梗塞范围的影响

为了解腺苷Ａ１受体激动剂ＲＰＩＡ对血一氧化氮（ＮＯ）水平及急性心肌梗塞范围的影响,２０只新西兰兔随机分为四组：Ⅰ,前降支缺血６０ｍｉｎ,再灌注９０ｍｉｎ;Ⅱ,缺血前１５ｍｉｎ给予ＲＰＩＡ（０．３ｍｇ／ｋｇ）ｉｖ,余同Ⅰ组;Ⅲ,两次缺血１０ｍｉｎ,间隔１０ｍｉｎ然后缺血６０ｍｉｎ,再灌注９０ｍｉｎ;Ⅳ,缺血前１５ｍｉｎ给予选择性腺苷Ａ１受体拮抗剂ＤＰＣＰＸ（１．０ｍｇ／ｋｇ）ｉｖ余同Ⅲ组。分别测定缺血再灌注期血ＮＯ水平、心率、平均血压及ｄｐ／ｄｔ,实验结束经ＴＴＣ染色测定心肌梗塞范围。结果显示,ＲＰＩＡｉｖ后血ＮＯ水平迅速上升达基础值二倍,并在整个缺血期持续高于对照组,同时伴有心率（２６．３％）和平均血压（１７．３％）的下降,ｄｐ／ｄｔ测值各组无明显差异。心肌梗塞范围,Ⅰ．２３．１±９．４％,Ⅱ．１２．１±２．２％,Ⅲ．１１．４±３．０％,Ⅳ．２１．４±７．８％。结论：缺血预适应（ＩＰＣ）减少急性心肌梗塞范围,腺苷Ａ１受体激动剂可以达到ＩＰＣ效果,而该受体阻滞可以取消ＩＰＣ效果;血ＮＯ水平的升高有可能是ＲＰＩＡ引起ＩＰＣ效应的原因之一。     

血管紧张素Ⅱ对大鼠心肌肌浆网Ca~(2+),Mg~(2+)-ATPase基因转录调节的影响

观察血管紧张素Ⅱ（ＡｎｇⅡ）对心肌肌浆网Ｃａ２＋,Ｍｇ２＋－ＡＴＰａｓｅ基因（ＳＥＲＣＡ２ａ）转录调节的影响,评价ＤＭＰ８１１对此效应的干预作用．６周龄雄性ＳＤ大鼠随机分为３组,每组６只．组１：生理盐水输注;组２：ＡｎｇⅡ输注＋ＤＭＰ８１１管饲（３ｍｇ·ｄ－１·ｋｇ－１）;组３：ＡｎｇⅡ输注（２００ｎｇ·ｍｉｎ－１·ｋｇ－１．１周后称其体重,取心脏并称重,提取心脏总ＲＮＡ后采用Ｎｏｒｔｈｅｒｎｂｌｏｔ的方法检测ＳＥＲ－ＣＡ２ａ的转录水平,采用ＲＴ－ＰＣＲ检测ＡｎｇⅡ１型受体（ＡＴ１）ｍＲＮＡ水平．实验后,组３心重（ＣＷ）、心重／体重（Ｃ／Ｂ）、ＡＴ１受体转录水平均高于组１（分别增加４．７±０．４％,４．９±０．９％和２４．７±３．５％;Ｐ＜０．０１）,而ＳＥＲＣＡ２ａ基因转录水平显著低于组１（降低２０．１±３．０％,Ｐ＜０．０１）,并且ＳＥＲＣＡ２ａｍＲＮＡ水平与ＡＴ１受体ｍＲＮＡ水平呈负相关（ｒ＝－０．７４,Ｐ＜０．０１）．ＡｎｇⅡ导致的上述改变能被ＤＭＰ８１１完全阻断．ＡｎｇⅡ通过其Ⅰ型受体的介导,诱导了ＳＥＲＣＡ２ａ的转录下调     

MPEG－SOD对急性低氧下鼠左心功能的保护作用

单甲氧基聚乙二醇（ＭＰＥＧ）活化后与超氧化物歧化酶（ＳＯＤ）偶联,经纯化后得到ＭＰＥＧ－ＳＯＤ,鉴定其分子量约为７．０×１０５Ｄａｔｉｏｎ。其在血液循环中酶活性半衰期超过３０ｈ,远大于天然ＳＯＤ（６－１０ｍｉｎ）。ＳＤ雄性大鼠分三组．对照组（ｎ＝８．由股静脉注入０．２ｍｌ生理盐水）、ＮａｔｉｖｅＳＯＤ组（ｎ＝８,注以０．２ｍｌ生理盐水配的８００ＵＳＯＤ）和ＭＰＥＧ－ＳＯＤ组（ｎ＝９,注以８００ＵＭＰＥＧ－ＳＯＤ）。低氧前三组鼠的心率（ＨＲ）、左室内峰压（ＬＶＰ）、左室压微分（ＬＶ±ｄｐ／ｄｔｍａｘ）和股动脉压（ＡＰ）均无统计学差别。在模拟６０００—６５００ｍ高度急性低氧１．８．１４ｍｉｎ记录上述各项指标,结果如下：除ＨＲ外,ＮａｔｉｖｅＳＯＤ组与对照组各指标均无统计学差别,ＭＰＥＧ－ＳＯＤ组的各项指标均明显高于对照组。表明ＭＰＥＧ－ＳＯＤ对急性低氧导致的左心室力学指标的减弱有明显保护作用,提示超氧自由基（Ｏ２－）在急性低氧导致左心室功能损伤中起重要作用,即可能是由Ｏ２－及其衍生的其它自由基损害心肌细胞生物膜系统所致。     

心衰心脏收缩蛋白分子变化及与收缩力的关系

采用ＤＯＣＡ硅胶管皮下埋入法建立大鼠心衰模型,从基因转录水平检测正常与心衰大鼠心肌组织中心肌收缩蛋白分子基因α－ＭＨＣ、β－ＭＨＣ、α－ｃａｒｄｉａｃａｃｔｉｎ、α－ｓｋｅｌｅｔａｌａｃｔｉｎ表达的变化。结果显示：（１）心衰大鼠心肌收缩力指标ｄｐ／ｄｔｍａｘ较正常大鼠明显降低（下降２７．５１％,Ｐ＜０．０１）,（２）心衰大鼠与正常大鼠相比,心肌组织中α－ＭＨＣ基因表达水平显著下降（降低２１．４３％,Ｐ＜０．０５）,β－ＭＨＣ基因表达水平显著升高（升高６２．４３％,Ｐ＜０．０１）、α－ｃａｒｄｉａｃａｃｔｉｎ基因和α－ｓｋｅｌｅｔａｌａｃｔｉｎ基因表达水平未见明显改变,（３）α－ＭＨＣｍＲＮＡ的含量与心肌收缩力指标ｄｐ／ｄｔｍａｘ值之间存在正相关关系（ｒ＝０．４１４３,ｎ＝４３,Ｐ＜０．０５）,β－ＭＨＣｍＲＮＡ的含量与ｄｐ／ｄｔｍａｘ值之间存在负相关关系。（ｒ＝－０．３９０２,ｎ＝４３,Ｐ＜０．０５）。这提示：心肌组织中ＭＨＣ基因表达水平的改变是心衰时心肌收缩力降低的主要分子基础     

青年男性高原移居者最大摄氧量计算公式的推导

最大摄氧量（Ｖｏ２ｍａｘ）是评价人体体力的重要指标,其测定方法分直接法和间接法两种。目前所推导的间接计算公式都是在平原、或是在进入高原初期推导的,不适用于高原习服人群。本研究采用逐步回归的方法,推导出移居高原７－２７个月、不同高度的青年男性Ｖｏ２ｍａｘ间接计算公式。在海拔３６８０ｍ地区,Ｖｏ２ｍａｘ（Ｌ／ｍｉｎ）＝１．１５３１＋０．００７３２７身高（ｃｍ）＋０．０１６１３体重（ｋｇ）－０．００５８８３晨脉（ｂ／ｍｉｎ）－０．００４５３４运动心率（６０Ｗ,６／ｍｉｎ）,Ｒ＝０．７４５,Ｐ＜０．０１,ＳＳ＝３．７７９９;或Ｖｏ２ｍａｘ（Ｌ／ｍｉｎ）＝１．２１８６＋０．０１９８４体重（ｋｇ）＋０．０７２５９肺活量（Ｌ）－０．００６６５９晨脉（ｂ／ｍｉｎ）,Ｒ＝０．７１３,ｐ＜０．０１,ｓｓ＝３．９６３６。在４３５０ｍ地区,Ｖｏ２．ｍａｘ（Ｌ／ｍｉｎ）＝０．４９１７＋０．０１６８７体重（ｋｇ）＋０．１１０９肺活量（Ｌ）＋０．００１９８３屏气时间（Ｓ）,Ｒ＝０．７８１,Ｐ＜０．０１,ＳＳ＝２．１３５６。计算值与实测值比较,变异系数在１３％以内,结果准确可靠,适用于青年男性高原习服移居者。     

心房钠尿肽对大鼠主动脉弓压力感受器活动的影响

在隔离灌流的大鼠主动脉弓－主动脉神经标本上,观察了心房肽Ⅲ（ａｔｒｉｏｐｅｐｔｉｎⅢ,ＡＰⅢ）对主动脉弓压力感受器活动的影响。主动脉弓内压保持１３．３ｋＰａ条件下向灌流液中加入ＡＰⅢ（２．０μｇ／ｍｌ）后,主动脉神经传入放电较对照值增加６４±２７％（Ｐ＜０．００１）;升降灌流压时,主动脉神经传入放电随之增减,饱和压（ＳＰ）由２２．５±０．５降至２１．３±０．５ｋＰａ（Ｐ＜０．０５）,工作范围（ＯＲ）由１２．１±０．４降至１０．６±０．４ｋＰａ（Ｐ＜０．０５）,阈压（ＴＰ）无明显变化;压力感受器机能曲线向左上方移位,曲线的最大积分值（ＰＩＶ）由５０８±６６％增至７３０±５２％（Ｐ＜０．０５）,曲线最大斜率（ＰＳ）由５５．６±７．５增至９３．２±６．８％·ｋＰａ－１（Ｐ＜０．０５）;冲洗掉ＡＰⅢ后,主动脉神经传入放电基本恢复至对照水平．主动脉弓内压保持在１３．３ｋＰａ条件下,向灌流液中加入硝普钠（ＮＰ,１．０μｇ／ｍｌ）,主动脉神经传入放电虽有所减少,但无统计学意义（Ｐ＞０．０５）;升降灌流压时,ＴＰ,ＳＰ,ＯＲ均无明显变化,对压力感受器机能曲线及ＰＳ也无显著影响,而ＰＩＶ由６６７±７８降至５０２±７４％（Ｐ＜     

中长跑运动的心血管效应

本研究通过利用彩色多普勒超声心动图对２４例专业中长跑运动员的心脏形态、血液动力学改变及收缩舒张功能参数进行了观察,并与２０例从未参加过正规训练的同龄案牍工作者对照组进行了对比研究,结果显示：中长跑运动员的舒张末期左室内径（ＬＶＤｄ）、左室舒张末容量（ＬＶＥＤＶ）、收缩末容量（ＬＶＥＳＶ）、每搏量（ＳＶ）、左室心肌重量（ＬＶＭ）及左室心肌重量指数（ＬＶＭＩ）均高于对照组（Ｐ＜０．０１）;舒张早期峰值血流速度（ＰＦＶＥｃｍ／ｓ）高于对照组（Ｐ＜０．０１）;舒张晚期峰值血流速度（ＰＦＶＡｃｍ／ｓ）,Ｅ峰面积（Ｅａｒｅａｍ）,舒张早期峰值血流速度与舒张晚期峰值血流速度比（ＰＦＶＥ／ＰＦＶＡ）也高于对照组（Ｐ＜０．０５）。而出现三尖辩肺动脉返流的比例也明显高于对照组（Ｐ＜０．０１）。认为：中长跑运动员不仅心脏形态大小及收缩功能有显著改变,而且在舒张功能也有明显变化     

急性低氧中枢加压素对循环活动的效应

为了解中枢加压素是否参与了低氧下循环活动的维持,本实验在同步监测麻醉大鼠血压（ＢＰ）,心率（ＨＲ）,左、右心室压（ＬＶＰ,ＲＶＰ）及其ｄｐ／ｄｔ的条件下,观察侧脑室注射（ｉｃｖ）加压素Ｖ１－、Ｖ２－受体拮抗剂（各４μｇ）及同体积人工脑脊液（ＡＣＳＦ）（８μｌ）三组不同处理大鼠在低氧下循环指标的变化。于侧脑室注射药物１０ｍｉｎ后,让大鼠吸入含氧９％的氮氧混合气体１５ｍｉｎ,然后复氧。实验中观察到三组     

刺激腓深神经对低血压或休克狗心血管活动的影响

实验在麻醉狗中进行。静脉内匀速注射硝普钠时,平均动脉压和左心室收缩压明显降低,左心室dp/dt_(max)、-dp/dt_(max)和心力环面积均明显减小。此时电刺激一侧腓深神经可使动脉血压和左心室收缩压明显升高,dp/dt_(max)和心力环面积也显著增加。停止刺激后,动脉血压和左心室收缩压逐渐回向刺激前的水平。停止注射硝普钠5～15分钟后,上述各项观察指标基本恢复到注药前的水平。在用大肠杆菌内毒素造成休克的狗中,电刺激一侧腓深神经,也能使平均动脉压和左心室收缩压升高,同时dp/dt_(max)、-dp/dt_(max)和肠系膜血管阻力明显增高,但肾血管阻力增加不明显。本实验结果与以往的实验资料一起表明,在用扩血管药造成低血压时,躯体神经刺激引起的升压效应似乎以心肌收缩力增加为主;而在内毒素休克时,躯体神经刺激可通过改善心肌收缩功能和增加内脏血管阻力而引起升压作用。     

鬼笔环肽对心肌梗死大鼠离体心脏牵张所致电生理学改变的影响

本文旨在探讨肌动蛋白稳定剂--鬼笔环肽(phalloidin)对心肌梗死(myocardial infarction,MI)大鼠离体心脏牵张所致电生理学改变的影响.将32只Wistar大鼠随机分为正常对照组(n=9)、鬼笔环肽组(n=7)、MI组(n=9)、MI 鬼笔环肽组(n=7).离体心脏经Langendorff灌流后,通过改变水囊容积,以△V=0.1、0.2、0.3 mL对心室牵张5 S,观察牵张后效应30 s,记录左心室内压力变化[左心室收缩压(left ventricular systolic pressure,LVSP)、左心室舒张末压(left ventricular end-diastolic pressure,LVEDP)、室内压最大上升,下降速率(±dp/dt max)]、单相动作电位复极90%的时程(monophasic action po-tential duration at 90%repolarization,MAPD 90)、室性期前收缩(premature ventricular beats,PVB)及室性心动过速(ventriculartachycardia,VT)发生率.结果显示,牵张使正常对照组及MI组大鼠MAPD 90明显延长(P<0.05,P<0.01),MI组大鼠MAPD 90延长更显著(P<0.05,P<0.01).鬼笔环肽(1 μmol/L)对正常及MI心肌基础状态下的MAPD 90无影响,但使MI心肌牵张后已延长的MAPD90缩短(△V=0.3 mL时,P<0.05).牵张后MI组大鼠PVB、VT的发生率明显高于正常对照组(均P<0.01).鬼笔环肽对正常大鼠心肌牵张后PVB、VT的发生率无显著影响,但使MI心肌PVB、VT的发生率明显下降(均P<0.01).MI组大鼠LVSP及 ap/dt max 较正常对照组显著降低(P<0.01);鬼笔环肽可使MI心肌LVSP轻度回升,但无统计学意义.结果表明,MI后牵张加重恶性心律失常的发生和持续,鬼笔环肽可以明显抑制其发生.     

共载体AAV-PR39-ADM治疗缺血性心脏病

目的:探讨共载体AAV-PR39-ADM分泌表达血管生成肽(PR39)与血管扩张肽(ADM)对SD大鼠心肌缺血再灌注损伤的作用。方法:选健康成年雄性SD大鼠36只,体重平均为280 g±20 g,随机分为假手术组(SO)、治疗组(TR)与对照组(I/R),每组各12只。治疗组大鼠心肌注射共载体AAV-PR39-ADM感染心肌7天后行B超检查,测量记录左室壁厚度及射血分数(EF%),左室收缩末压(LVSP),左室内压最大上升下降速率(±dp/dt max)评价作为心脏功能指标。对照组建立缺血再灌注损伤模型,假手术组只穿线不结扎且两组行相同检测。速取处死大鼠心肌行masson染色测量心肌梗死面积。结果:治疗组明显高于对照组,其射血分数、左室内收缩末压、最大上升速率,最大下降速率、梗死面积分别为:EF%(50.4±6.3),(29.8±10.5),P0.05;LVSP:(116±4.2),(101±3.7),P0.05;+dp/dt max:(2859±365),(2137±191),P0.05;-dp/dtmax:(2186±107),(1886±124),P0.05;IS%:(29.3±4.6),(24.6±2.2),P0.05。结论:共载体AAV-PR39-ADM能够显著恢复心肌缺血损伤引起的左室内压下降,提高心肌收缩能力,提高射血分数并明显缩小心肌梗死范围。     

硫化氢对大鼠心肌缺血/再灌注损伤的保护作用及其对c-Fos蛋白表达的影响

为探讨硫化氢(hydrogen sulfide,H2S)对大鼠心肌缺血,再灌注(ischemia/reperfusion,I/R)损伤的保护作用及机制,雄性Sprague-Dawley大鼠被随机分为对照组(假手术组)、I/R组、2.8μmol/kg体重NaHS干预组、14 μmol/kg体重NaHS干预组.结扎冠状动脉前降支30 min后,松扎再灌注60 min,心电图Ⅱ导联检测和TTC染色测定心肌梗死面积评价制作的心肌I/R模型:测定血浆中H2S浓度变化;监测血流动力学指标(LVSP,LV±dp/dtmax);HE染色和透射电镜观察心肌形态学改变;免疫组织化学方法测定心肌组织中c-Fos蛋白表达.结果显示:心肌I/R后血浆中H2S浓度明显低于对照组[(30.32±5.26)vs(58.28±7.86)μmol/L,P<0.05]:2.8和14μmol/kg体重NaHS均可显著改善I/R引起的心功能改变,且14μmol/kg体重NaHS较2.8 μmol/kg体重NaHS作用强;14 μmol/kg体重NaHS明显减轻心肌形态学及超微结构损伤,同时降低大鼠I/R心肌组织中c-Fos蛋白表达(0.20±0.06vs0.32±0.10,P<0.05).以上结果提示,H2S对大鼠心肌的I/R损伤有保护作用,这可能与其降低c-Fos蛋白表达有关.     

The effect of changes in cardiac frequency on left and right ventricular dP/dt max at different contractile states of the myocardium

In 17 canine heart-lung preparations the dependence of frequency potentiation of the right and left ventricular myocardium on the basic inotropic state of the heart was investigated. The effect of unipolar stimulation of the right atrium on dP/dt max in both ventricles was measured. The aortic pressure was maintained constant. Shortly after isolation of the heart, a stepwise increase of rate from 140 to 200 beats/min only had a very weak influence on left ventricular dP/dt max. With deterioration of the myocardium the frequency potentiation of dP/dt max increased considerably. End-diastolic pressure regularly decreased with rising cardiac frequency. Since the real positive inotropic effect is masked by the concomitant fall in diastolic loading, the end-diastolic pressure was maintained constant in a second group of 8 hearts during rate variation. The most pronounced inotropic effect was now found shortly after isolation of the heart. A rate increase of 30 beats/min resulted in a 20% rise of dP/dt max. The frequency potentiation decreased with deterioration of the heart resulting in a 12% dP/dt max increase at an estimated inotropic state of 50% of control. When the contractile state of the heart was improved above the control state by calcium application the frequency potentiation of the myocardium decreased. In the right ventricle similar results were obtained except for the fact that no significant correlation between the steepness of the frequency characteristics and the contractile state of the heart could be found when the end-diastolic pressure was kept constant.     

Assessing left ventricular systolic dysfunction after myocardial infarction: are ejection fraction and dP/dt(max) complementary or redundant?

Among the various cardiac contractility parameters, left ventricular (LV) ejection fraction (EF) and maximum dP/dt (dP/dt(max)) are the simplest and most used. However, these parameters are often reported together, and it is not clear if they are complementary or redundant. We sought to compare the discriminative value of EF and dP/dt(max) in assessing systolic dysfunction after myocardial infarction (MI) in swine. A total of 220 measurements were obtained. All measurements included LV volumes and EF analysis by left ventriculography, invasive ventricular pressure tracings, and echocardiography. Baseline measurements were performed in 132 pigs, and 88 measurements were obtained at different time points after MI creation. Receiver operator characteristic (ROC) curves to distinguish the presence or absence of an MI revealed a good predictive value for EF [area under the curve (AUC): 0.998] but not by dP/dt(max) (AUC: 0.69, P < 0.001 vs. EF). Dividing dP/dt(max) by LV end-diastolic pressure and heart rate (HR) significantly increased the AUC to 0.87 (P < 0.001 vs. dP/dt(max) and P < 0.001 vs. EF). In na?ve pigs, the coefficient of variation of dP/dt(max) was twice than that of EF (22.5% vs. 9.5%, respectively). Furthermore, in n = 19 pigs, dP/dt(max) increased after MI. However, echocardiographic strain analysis of 23 pigs with EF ranging only from 36% to 40% after MI revealed significant correlations between dP/dt(max) and strain parameters in the noninfarcted area (circumferential strain: r = 0.42, P = 0.05; radial strain: r = 0.71, P < 0.001). In conclusion, EF is a more accurate measure of systolic dysfunction than dP/dt(max) in a swine model of MI. Despite the variability of dP/dt(max) both in na?ve pigs and after MI, it may sensitively reflect the small changes of myocardial contractility.     

Determination of cardiac contractility in awake unsedated mice with a fluid-filled catheter

Today, cardiac contractility in mice is exclusively measured under anesthesia or in sedated animals because the catheters available are too rigid to be used in awake mice. We therefore developed a new catheter (Pebax 03) to measure cardiac contractility in conscious mice. In this study, we evaluated the accuracy and utility of this new catheter for assessment of cardiac contractility in anesthetized and conscious mice. With the use of a balloon-pop test, the Pebax catheter with an inner diameter of 0.3 mm was found to exhibit a high natural frequency, a low damping coefficient, and a flat frequency of up to 50.5 +/- 0.6 Hz. Under anesthesia (0.5% or 1.0% halothane), no difference was found in heart rate (HR), left ventricular (LV) systolic pressure (LVSP), the maximum rates of LV pressure rise and fall (LV dP/dt(max) and LV dP/dt(min), respectively), ejection time (ET), and isovolumic relaxation time constant (tau) when measured with either the 1.4-Fr Millar or Pebax 03 catheter. However, when HR, LVSP, LV dP/dt(max), and LV dP/dt(min) were recorded with the Pebax catheter in awake mice, values were significantly higher, and ET and tau were lower, than under anesthesia, suggesting a major impact of anesthesia on these parameters. The Pebax catheter was also used in a normotensive one-renin gene mouse model of cardiac hypertrophy induced by DOCA and salt. In this model, DOCA-salt induced a severe decrease in cardiac contractility in the absence of changes in blood pressure. These data demonstrate that cardiac contractility can be measured very accurately in conscious mice. This new device can be of great help in the investigation of cardiac function in normal and genetically engineered mice.     

急性低氧下钙阻断剂对左,右心泵功能的影响

在20条麻醉开胸狗上,用RM-6000多道仪同步记录左心室内峰压(LVP)、左室压力变化率(L+dP/dt_(max))、右心室内峰压(RVP)、右室压力变化率(R±dp/dt_(max))、肺动脉压力(P_(Pa))、主动脉血流每搏峰值(Fa)、心率(HR)等各项生理指标,观察钙通道阻断剂Nife-dipine,Diltiazem和Verapamil对左、右心室功能影响。在钙通道阻断剂处理后,左室的LVP,L±dp/dt_(max)下降,而Fa增加;右室的RVF,R±dp/dt_(max)和P_(Pa)均有升高趋势,显示钙通道阻断剂对左、右心泵功能的影响不同。这可能提示左、右心室功能对钙离子的依赖程度不同。在急性低氧状态下,此三种钙阻断剂均使急性低氧引起LVP的增加反应消失,Fa增加明显,Verapamil和Diltiazem有减轻急性低氧引起的RVP和P_(Pa)的增压作用。从这些钙通道阻断剂对左右心泵功能影响的比较来看,Diltiazem比Verapamil和Nifedipine对急性低氧状态下的心泵功能有较好的作用。     

Effects of avertin versus xylazine-ketamine anesthesia on cardiac function in normal mice

Anesthetic regimens commonly administered during studies that assess cardiac structure and function in mice are xylazine-ketamine (XK) and avertin (AV). While it is known that XK anesthesia produces more bradycardia in the mouse, the effects of XK and AV on cardiac function have not been compared. We anesthetized normal adult male Swiss Webster mice with XK or AV. Transthoracic echocardiography and closed-chest cardiac catheterization were performed to assess heart rate (HR), left ventricular (LV) dimensions at end diastole and end systole (LVDd and LVDs, respectively), fractional shortening (FS), LV end-diastolic pressure (LVEDP), the time constant of isovolumic relaxation (tau), and the first derivatives of LV pressure rise and fall (dP/dt(max) and dP/dt(min), respectively). During echocardiography, HR was lower in XK than AV mice (250 +/- 14 beats/min in XK vs. 453 +/- 24 beats/min in AV, P < 0.05). Preload was increased in XK mice (LVDd: 4.1 +/- 0.08 mm in XK vs. 3.8 +/- 0.09 mm in AV, P < 0.05). FS, a load-dependent index of systolic function, was increased in XK mice (45 +/- 1.2% in XK vs. 40 +/- 0.8% in AV, P < 0.05). At LV catheterization, the difference in HR with AV (453 +/- 24 beats/min) and XK (342 +/- 30 beats/min, P < 0.05) anesthesia was more variable, and no significant differences in systolic or diastolic function were seen in the group as a whole. However, in XK mice with HR <300 beats/min, LVEDP was increased (28 +/- 5 vs. 6.2 +/- 2 mmHg in mice with HR >300 beats/min, P < 0.05), whereas systolic (LV dP/dt(max): 4,402 +/- 798 vs. 8,250 +/- 415 mmHg/s in mice with HR >300 beats/min, P < 0.05) and diastolic (tau: 23 +/- 2 vs. 14 +/- 1 ms in mice with HR >300 beats/min, P < 0.05) function were impaired. Compared with AV, XK produces profound bradycardia with effects on loading conditions and ventricular function. The disparate findings at echocardiography and LV catheterization underscore the importance of comprehensive assessment of LV function in the mouse.     

Ischemic and anesthetic preconditioning reduces cytosolic [Ca2+] and improves Ca(2+) responses in intact hearts

Ca(+) loading during reperfusion after myocardial ischemia is linked to reduced cardiac function. Like ischemic preconditioning (IPC), a volatile anesthetic given briefly before ischemia can reduce reperfusion injury. We determined whether IPC and sevoflurane preconditioning (SPC) before ischemia equivalently improve mechanical and metabolic function, reduce cytosolic Ca(2+) loading, and improve myocardial Ca(2+) responsiveness. Four groups of guinea pig isolated hearts were perfused: no ischemia, no treatment before 30-min global ischemia and 60-min reperfusion (control), IPC (two 2-min occlusions) before ischemia, and SPC (3.5 vol%, two 2-min exposures) before ischemia. Intracellular Ca(2+) concentration ([Ca(2+)](i)) was measured at the left ventricular (LV) free wall with the fluorescent probe indo 1. Ca(2+) responsiveness was assessed by changing extracellular [Ca(2+)]. In control hearts, initial reperfusion increased diastolic [Ca(2+)] and diastolic LV pressure (LVP), and the maximal and minimal derivatives of LVP (dLVP/dt(max) and dLVP/dt(min), respectively), O(2) consumption, and cardiac efficiency (CE). Throughout reperfusion, IPC and SPC similarly reduced ischemic contracture, ventricular fibrillation, and enzyme release, attenuated rises in systolic and diastolic [Ca(2+)], improved contractile and relaxation indexes, O(2) consumption, and CE, and reduced infarct size. Diastolic [Ca(2+)] at 50% dLVP/dt(min) was right shifted by 32-53 +/- 8 nM after 30-min reperfusion for all groups. Phasic [Ca(2+)] at 50% dLVP/dt(max) was not altered in control but was left shifted by -235 +/- 40 nM [Ca(2+)] after IPC and by -135 +/- 20 nM [Ca(2+)] after SPC. Both SPC and IPC similarly reduce Ca(2+) loading, while augmenting contractile responsiveness to Ca(2+), improving postischemia cardiac function and attenuating permanent damage.